GUP1 activators encompass a specialized category of biochemical agents aimed at enhancing the activity of GUP1, a glycerol uptake protein involved in lipid metabolism and the maintenance of cellular membrane integrity. The development of GUP1 activators is predicated on a nuanced understanding of GUP1's structural and functional role within the cell, particularly its contribution to lipid remodeling and homeostasis. The discovery process for these activators typically employs high-throughput screening (HTS) techniques, enabling the rapid assessment of large compound libraries to identify molecules capable of upregulating GUP1 activity. This screening is designed to pinpoint compounds that can either directly interact with GUP1 to increase its enzymatic efficiency or modulate its expression at the genetic level, thereby enhancing its functional activity. Identifying effective GUP1 activators is essential for probing the biological pathways GUP1 influences, offering insights into its regulatory mechanisms in lipid metabolism and potential implications for membrane dynamics.
Following the initial identification phase, structure-activity relationship (SAR) studies play a crucial role in refining these activators, focusing on optimizing their efficacy and selectivity. SAR studies involve meticulous alterations to the chemical structures of promising compounds, examining how these modifications impact their ability to stimulate GUP1 activity. Through this iterative process, researchers aim to enhance the interaction between the activators and GUP1, ensuring that the compounds are both potent and specific in their action, with minimal off-target effects. Advanced analytical techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to elucidate the molecular interactions between GUP1 and the activators, providing critical insights into the activation mechanism. Additionally, cellular assays are integral to this development process, validating the activators' functional impact within a biological context. These assays confirm the capacity of the activators to effectively enhance GUP1 activity in living cells, elucidating their effects on lipid metabolism and membrane function. Through a comprehensive approach that combines targeted chemical synthesis, structural biology, and functional validation, GUP1 activators are meticulously developed to precisely modulate the activity of GUP1. This targeted modulation not only advances our understanding of GUP1's role in cellular physiology but also opens avenues for exploring its potential in conditions related to lipid dysregulation and membrane abnormalities.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can regulate gene expression by activating nuclear receptors, which may lead to changes in lipid metabolism genes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, potentially affecting cAMP levels and thus influencing gene transcription. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, potentially leading to compensatory mechanisms that alter lipid-associated gene expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium impacts glycogen synthase kinase-3 (GSK-3) activity, which may indirectly influence lipid-related gene transcription. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPARγ agonist, pioglitazone may modulate the transcription of genes involved in lipid metabolism. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, potentially leading to the demethylation and activation of certain genes. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
Cholesterol is a key lipid molecule that can affect the regulation of lipid metabolism and biosynthesis pathways. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine serves as a lipid signaling molecule that may influence the expression of genes related to lipid metabolism. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid is a fatty acid that can modulate lipid profiles and potentially affect gene regulation related to lipid processing. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Palmitic acid, as a saturated fatty acid, may influence lipid metabolic pathways and gene expression. | ||||||